|
No (N = 68) |
Yes (N = 25) |
|
Spontaneous type-1, n (%) |
51 (75) |
16 (66.7) |
0.430 |
Symptoms |
12 (17.6) |
5 (20.8) |
0.764* |
Syncope, n (%) |
5 (7.4) |
5 (20.8) |
0.120* |
SCD, n (%) |
7 (10.3) |
0 (0) |
0.184* |
FH of SCD, n (%) |
36 (52.9) |
18 (72) |
0,090 |
PR (ms), mean ± SD |
168 ± 26 |
182 ± 42 |
0.049** |
QRS duration DII (ms), mean ± SD |
105 ± 18 |
110 ± 21 |
0.336** |
QRS duration in V2 (ms), mean ± SD |
105 ± 18.4 |
107 ± 20.7 |
0.696** |
aVR sign, n/N (%) |
9/66 (13.6) |
13/23 (56.5) |
<0.001 |
S-wave in lead I, n/N (%) |
32/66 (48.5) |
18/23 (78.3) |
0.015 |
ER peripheral leads, n/N (%) |
7/65 (10.8) |
1/23 (4.3) |
0.675 |
QRS-f, n/N (%) |
5/65(7.7) |
7/23 (30.4) |
0.012* |
Inducible VT/VF, n/N (%) |
18/48 (37.5) |
6/16 (37.5) |
1.000 |
HV interval, mean ± SD |
49 ± 7 |
67 ± 16 |
<0.001** |
eVRP<200ms, n/N (%) |
7/38 (18.4) |
2/16 (12.5) |
0.709* |
LAE, n/N (%) |
3/27 (11.1) |
3/10 (30) |
0.313* |